Diseases, Conditions, Syndromes

Researchers find genetic cause of Raynaud's phenomenon

Researchers at Queen Mary University of London's Precision Healthcare Research Institute (PHURI) and the Berlin Institute of Health (BIH) at Charité—Universitätsmedizin Berlin have identified the genetic causes of Raynaud's ...

Medications

Q&A: Botox for migraines

I have suffered with migraines on and off for about five years. Recently, the oral therapy I've used seems to be less effective. While I know newer medications are available, a friend suggested I try Botox injections. She ...

Neuroscience

The anatomy of pain

Grimacing, we flinch when we see someone accidentally hit their thumb with a hammer. But is it really pain we feel? Researchers at the Max Planck Institute for Human Cognitive and Brain Sciences in Leipzig and other institutions ...

Medications

Marijuana component could ease pain from chemotherapy drugs

A chemical component of the marijuana plant could prevent the onset of pain associated with drugs used in chemo therapy, particularly in breast cancer patients, according to researchers at Temple University's School of Pharmacy.

Neuroscience

Renewed hope for treatment of pain and depression

Researchers at the Department of Infection and Immunity of the Luxembourg Institute of Health (LIH) have developed LIH383, a novel molecule that binds to and blocks a previously unknown opioid receptor in the brain, thereby ...

Neuroscience

Pain and itch connected down deep

A new study of itch adds to growing evidence that the chemical signals that make us want to scratch are the same signals that make us wince in pain.

Medical research

Can a dangerous microbe offer a new way to silence pain?

Anthrax has a scary reputation. Widely known to cause serious lung infections in humans and unsightly, albeit painless, skin lesions in livestock and people, the anthrax bacterium has even been used as a weapon of terror.

page 4 from 14